Distinctive Role of 6-month-Teriparatide on Intractable Bisphosphonate-Related Osteonecrosis of the Jaws (BRONJ)

Συνεισφορές: K. M. Kim, W. Park, S. Y. Oh, H.-J. Kim, W. Nam, S.-K. Lim, Y. Rhee, I. H. Cha, Kim, Hyung Jun, Nam, Woong, Park, Wonse, Rhee, Yumie, Lim, Sung Kil, Cha, In Ho

Θεματικοί όροι: Aged, 80 and over, Biomarkers/blood, Bisphosphonate-Associated Osteonecrosis of the Jaw/blood, Bisphosphonate-Associated Osteonecrosis of the Jaw/diagnostic imaging, Bisphosphonate-Associated Osteonecrosis of the Jaw/drug therapy, Bisphosphonate-Associated Osteonecrosis of the Jaw/physiopathology, Bone Density/drug effects, Bone Density Conservation Agents/therapeutic use, Bone Remodeling/drug effects, Combined Modality Therapy, Drug Evaluation/methods, Female, Femur Neck/physiopathology, Hip Joint/physiopathology, Humans, Longitudinal Studies, Lumbar Vertebrae/physiopathology, Male, Middle Aged, Radiography, Retrospective Studies, Severity of Illness Index, Teriparatide/therapeutic use, Treatment Outcome, Vitamin D/blood, Bisphosphonate, Jaw, Osteonecrosis, Teriparatide

Περιγραφή αρχείου: 1625~1632

Relation: OSTEOPOROSIS INTERNATIONAL; J02451; https://ir.ymlib.yonsei.ac.kr/handle/22282913/98548; T201401021; 57664

Διαθεσιμότητα: https://ir.ymlib.yonsei.ac.kr/handle/22282913/98548
https://doi.org/10.1007/s00198-014-2622-8
http://link.springer.com/article/10.1007%2Fs00198-014-2622-8